ARQTArcutis Biotherapeutics, Inc.

ARQT Stock Price, Valuation & Chart | Arcutis Biotherapeutics, Inc.

Compare

$23.850+0.10 (+0.42%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ARQT intrinsic value ARQT calculated fair value vs price

Overview Financials Dividends Ratios

ARQT Historical price chart

ARQT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.98B

PE Ratio113.57

EPS0.21

Trading Volume1.88M

Today's High/Low24.45/23.4

Dividend Yield0.00

52 Week High/Low31.77/15.13

Shares Outstanding125.08M

ARQT Financial Statement

ARQT Analyst ratings

ARQT Analysis & performance metrics

ARQT Company profile

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is…

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of…

ARQT Management team

Name

Position

Rajvir Madan

Chief Digital & Technology Officer

Todd Franklin Watanabe M.A.CEO

President, Chief Executive Officer & Director

Masaru Matsuda Esq., J.D.

Senior Vice President, General Counsel & Corporate Secretary

Latha VairavanCFO

Chief Financial Officer

Amanda Sheldon

Head of Corporate Communications

Kent Taylor

Senior Vice President of Sales

Aleen Hosdaghian

Vice President of Marketing

Patrick E. Burnett M.D., Ph.D.

Executive Vice President & Chief Medical Officer

Name

Position

Rajvir Madan

Chief Digital & Technology Officer

Todd Franklin Watanabe M.A.CEO

President, Chief Executive Officer & Director

Masaru Matsuda Esq., J.D.

Senior Vice President, General Counsel & Corporate Secretary

Latha VairavanCFO

Chief Financial Officer

Amanda Sheldon

Head of Corporate Communications

Kent Taylor

Senior Vice President of Sales

Aleen Hosdaghian

Vice President of Marketing

Patrick E. Burnett M.D., Ph.D.

Executive Vice President & Chief Medical Officer

Management Team

Rajvir Madan

Chief Digital & Technology Officer

Todd Franklin Watanabe M.A.CEO

President, Chief Executive Officer & Director

Masaru Matsuda Esq., J.D.

Senior Vice President, General Counsel & Corporate Secretary

Latha VairavanCFO

Chief Financial Officer

Amanda Sheldon

Head of Corporate Communications

Kent Taylor

Senior Vice President of Sales

Aleen Hosdaghian

Vice President of Marketing

Patrick E. Burnett M.D., Ph.D.

Executive Vice President & Chief Medical Officer

Management

Rajvir Madan

Chief Digital & Technology Officer

Todd Franklin Watanabe M.A.CEO

President, Chief Executive Officer & Director

Masaru Matsuda Esq., J.D.

Senior Vice President, General Counsel & Corporate Secretary

Latha VairavanCFO

Chief Financial Officer

Amanda Sheldon

Head of Corporate Communications

Kent Taylor

Senior Vice President of Sales

Aleen Hosdaghian

Vice President of Marketing

Patrick E. Burnett M.D., Ph.D.

Executive Vice President & Chief Medical Officer

Total 8 executives

ARQT Frequently asked questions

What is Arcutis Biotherapeutics, Inc. (ARQT) Stock Price?

Current stock price of Arcutis Biotherapeutics, Inc. (ARQT) stock is $23.850. The stock price is +0.42% higher in the session. The intraday range can be seen from this page. Volume of Arcutis Biotherapeutics, Inc. (ARQT) stock is 1.88M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Arcutis Biotherapeutics, Inc. (ARQT) stock price going up or down today?

The stock price of Arcutis Biotherapeutics, Inc. (ARQT) can change with earnings, company news, and overall market sentiment. Arcutis Biotherapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Arcutis Biotherapeutics, Inc. stock expensive at its current price?

Whether Arcutis Biotherapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ARQT on this page is 113.57. EPS on this page is 0.21. Compare those figures with peers and growth expectations before deciding if the current Arcutis Biotherapeutics, Inc. price is justified.

How has the stock price of Arcutis Biotherapeutics, Inc. (ARQT) performed historically?

Historical performance for Arcutis Biotherapeutics, Inc. (ARQT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ARQT reacted to past earnings and market events.

Should I buy Arcutis Biotherapeutics, Inc. (ARQT) stock, at this price?

Buying Arcutis Biotherapeutics, Inc. (ARQT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.